SG11201911732TA - Cell composition, method of production and its use in corneal diseases - Google Patents

Cell composition, method of production and its use in corneal diseases

Info

Publication number
SG11201911732TA
SG11201911732TA SG11201911732TA SG11201911732TA SG11201911732TA SG 11201911732T A SG11201911732T A SG 11201911732TA SG 11201911732T A SG11201911732T A SG 11201911732TA SG 11201911732T A SG11201911732T A SG 11201911732TA SG 11201911732T A SG11201911732T A SG 11201911732TA
Authority
SG
Singapore
Prior art keywords
production
cell composition
corneal diseases
corneal
diseases
Prior art date
Application number
SG11201911732TA
Inventor
Sayan Basu
Vivek Singh
Original Assignee
Hyderabad Eye Res Foundation
Hyderabad Eye Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hyderabad Eye Res Foundation, Hyderabad Eye Inst filed Critical Hyderabad Eye Res Foundation
Publication of SG11201911732TA publication Critical patent/SG11201911732TA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/363—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4833—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0621—Eye cells, e.g. cornea, iris pigmented cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21005—Thrombin (3.4.21.5)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2513/00—3D culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/52—Fibronectin; Laminin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/56—Fibrin; Thrombin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SG11201911732TA 2017-06-09 2018-06-09 Cell composition, method of production and its use in corneal diseases SG11201911732TA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN201741020290 2017-06-09
PCT/IB2018/054183 WO2018225042A1 (en) 2017-06-09 2018-06-09 Cell composition, method of production and its use in corneal diseases

Publications (1)

Publication Number Publication Date
SG11201911732TA true SG11201911732TA (en) 2020-01-30

Family

ID=64566584

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201911732TA SG11201911732TA (en) 2017-06-09 2018-06-09 Cell composition, method of production and its use in corneal diseases

Country Status (5)

Country Link
US (1) US20210093674A1 (en)
AU (1) AU2018280568A1 (en)
CA (1) CA3066311A1 (en)
SG (1) SG11201911732TA (en)
WO (1) WO2018225042A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013184843A1 (en) * 2012-06-05 2013-12-12 The Regents Of The University Of California Novel methods to regenerate human limbal stem cells

Also Published As

Publication number Publication date
WO2018225042A1 (en) 2018-12-13
AU2018280568A1 (en) 2020-01-16
US20210093674A1 (en) 2021-04-01
CA3066311A1 (en) 2018-12-13

Similar Documents

Publication Publication Date Title
IL271912A (en) Production of cannabinoids in yeast
IL273013A (en) Cell aggregate including retinal tissue and production method therefor
EP3349783C0 (en) Compositions and methods relating to the treatment of diseases
EP3335034A4 (en) Solid state electrodes, methods of making, and methods of use in sensing
EP3242672A4 (en) Amnion derived therapeutic composition and process of making same
PL3416658T3 (en) Human functional corneal endothelial cell and application thereof
EP3156081A4 (en) Cell structure for use in treatment of brain injury, method for producing same, and therapeutic agent for brain injury
EP3160493A4 (en) Compositions and methods to regulate renalase in the treatment of diseases and disorders
EP3139935A4 (en) Therapeutic placental compositions, methods of making and methods of use
HK1216146A1 (en) Ophthalmic composition, method for preparing the same, and use of the same
IL246202A0 (en) Methods of t cell epitope profiling, making t cell compositions, and treating diseases
EP3373910C0 (en) Echinomycin formulation, method of making and method of use thereof
PT3551748T (en) Perinatal tissue derived mesenchymal stem cells: method of preparation and uses thereof
IL263341A (en) Stem cell material, compositions, and methods of use
EP3607961A4 (en) Use of plant extract in preparing composition for increasing expression of tgm1, krt, aqp3, flg, gba, and has genes
IL268363A (en) Electrode composition, electrode, production method for said electrode, and battery
EP3515444A4 (en) Composition for treating ocular diseases and methods of usage and making
IL250495B (en) Stem cell compositions and methods of producing stem cells for therapeutic applications
GB201519200D0 (en) Skin care composition and method thereof
HK1232159A1 (en) Pharmacological ophthalmic composition for use in the correction of presbyopia and its administration
PL3316359T3 (en) Composition for electrochemical device electrode, electrode for electrochemical device, electrochemical device, and method of producing composition for electrochemical device electrode
EP3634438A4 (en) Compositions for treating retinal diseases and methods for making and using them
EP3389620A4 (en) Stem cell stimulating compositions and methods of treating melasma
HK1259451A1 (en) Skin care composition and method thereof
EP3394174A4 (en) Composition, method of making composition, and article